Kathleen Sebelius

Filings by Kathleen Sebelius span 4 companies, the busiest being Exact Sciences Corp, Humacyte, Inc. and Myovant Sciences Ltd. Between 13 June 2018 and 8 April 2025, the trades on record add up to 22 filings.

In open-market terms, that means 5 purchases worth €100k on one side and 2 sales worth €25k on the other. The net balance comes to €74k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 9 share grants and 5 option exercises. So far in 2025, the count stands at 1 purchase and no sales.

A typical purchase (the median) is worth €2,369. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 8 April 2025: an open-market purchase of €60k, in Humacyte, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.